Center news & funding
Massey researchers recognized with VCU distinguished faculty awards
VCU Massey Cancer Center’s director, Gordon Ginder, M.D., and Massey researcher, Thomas Eissenberg, Ph.D., were recognized with prestigious awards at Virginia Commonwealth University’s 2015 Opening Faculty Address and Convocation on Tuesday, August 18. Awards were presented to faculty members who have distinguished themselves and the university through their commitment to excellence, service, teaching and scholarship.
Massey researcher receives grant funding to support further pre-clinical testing of a promising neuroblastoma therapy
VCU Massey Cancer Center researcher Anthony Faber, Ph.D., was awarded a $250,000 grant from Alex’s Lemonade Stand Foundation to support further laboratory research to provide the validation needed to develop clinical trials to test a new therapy for neuroblastoma, the second deadliest cancer in children.
Massey researcher awarded grant to further develop a novel therapy for neuroblastoma
VCU Massey Cancer Center researcher Anthony Faber, Ph.D., was awarded a $46,000 grant from the Rally Foundation for Childhood Cancer Research and The Truth 365 to support his research to develop a new therapy for neuroblastoma, a rare type of cancer that develops in infants and young children.
Renowned cell biologist and biochemist Lewis Cantley keynotes Massey’s annual Cancer Research Retreat
It was the Friday before Memorial Day Weekend, but that didn’t stop more than 140 attendees from participating in VCU Massey Cancer Center’s annual Cancer Research Retreat. Similar to past retreats, the morning featured lectures from Massey research members as well as a keynote address by cell biologist and biochemist Lewis Cantley, Ph.D., Margaret and Herman Sokol Professor in Oncology Research and director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. In the afternoon, more than 60 student researchers and postdoctoral fellows displayed abstracts in the poster session and competed for up to $250 in Excellence in Cancer Research Awards.
Massey welcomes William McGuire as director of the Phase I Solid Tumor Program
VCU Massey Cancer Center welcomes physician-researcher William McGuire III, M.D., as the director of the Phase 1 Solid Tumor Program. Also a medical oncologist and member of the Developmental Therapeutics research program at Massey, McGuire joined the VCU Department of Internal Medicine in fall 2014 as a professor of medicine in the Division of Hematology, Oncology and Palliative Care. An expert in gynecologic cancers and developmental therapeutics, McGuire was instrumental in the development of paclitaxel as part of the standard of care for advanced ovarian cancer.